Spots Global Cancer Trial Database for oesophageal cancer
Every month we try and update this database with for oesophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | NCT04969835 | Pancreatic Canc... Colorectal Canc... Non-small Cell ... Head and Neck C... Cancer of Unkno... Ovarian Cancer Breast Cancer Soft Tissue Sar... Bladder Cancer Oesophageal Can... Prostate Cancer Biliary Tract C... | AVA6000 | 18 Years - | Avacta Life Sciences Ltd | |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | NCT04969835 | Pancreatic Canc... Colorectal Canc... Non-small Cell ... Head and Neck C... Cancer of Unkno... Ovarian Cancer Breast Cancer Soft Tissue Sar... Bladder Cancer Oesophageal Can... Prostate Cancer Biliary Tract C... | AVA6000 | 18 Years - | Avacta Life Sciences Ltd | |
| Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study | NCT06364553 | Oesophageal Can... | Esophageal self... | 18 Years - | Erasmus Medical Center | |
| Pre- and Post-Operative Exercise Program in Upper Gastrointestinal Cancers | NCT03807518 | Exercise Interv... | Standard Exerci... | 18 Years - | Royal College of Surgeons, Ireland | |
| BT1718 in Patients With Advanced Solid Tumours. | NCT03486730 | Advanced Solid ... Non-Small Cell ... Non-Small Cell ... Oesophageal Can... | BT1718 | 16 Years - | Cancer Research UK | |
| Oesophagectomy and Chest Wall and Respiratory Function | NCT03835273 | Esophageal Canc... Esophagectomy Respiratory Fun... | 3D motion captu... Incentive spiro... Questionnaires | 18 Years - 90 Years | Imperial College London | |
| A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer | NCT02489201 | Oesophageal Can... | donafenib tosil... | 18 Years - | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | |
| A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer | NCT03212469 | Head and Neck S... Lung Cancer Oesophageal Can... | Durvalumab Tremelimumab SBRT | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment | NCT04440800 | Lung Cancer, Sm... Pancreatic Canc... Gastric Cancer Oesophageal Can... Lung Cancer, No... Lung Cancer Met... | Wearable activi... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Determination of the Role of Microarray for Prognosis and Prediction to Chemotherapy Sensitivity in Patients With Operable, Locally Advanced and Metastatic Oesophageal Cancer | NCT00220077 | Oesophageal Can... | Endoscopy | 18 Years - | Royal Marsden NHS Foundation Trust | |
| ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) Cancer | NCT04603339 | Oesophageal Can... Gastric Cancer | Multidisciplina... | 18 Years - 100 Years | University of Dublin, Trinity College | |
| A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer | NCT01843829 | Oesophageal Can... | Oxaliplatin Capecitabine Carboplatin Paclitaxel Radiotherapy Surgery | 18 Years - | Velindre NHS Trust | |
| Laser Speckle Contrast Imaging, Surgical Eye & ICG Fluorescence Imaging for Perfusion Assessment of the Gastric Conduit | NCT05685862 | Oesophageal Can... | Laser Speckle C... | 18 Years - | Medical Centre Leeuwarden | |
| Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel | NCT04237090 | Breast Cancer Lung Cancer Ovarian Cancer Oesophageal Can... Head Cancer Nec... Cervical Cancer Endometrial Can... | Diphenhydramine Cetirizine Lactose pill Sodium chloride... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Anorexia iN Cancer Patients: ANCHOR | NCT04791254 | Gastric Cancer Oesophageal Can... | 18 Years - | The Christie NHS Foundation Trust | ||
| Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) | NCT04232735 | Oesophageal Can... Gastric Cancer | Tool and traini... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Anorexia iN Cancer Patients: ANCHOR | NCT04791254 | Gastric Cancer Oesophageal Can... | 18 Years - | The Christie NHS Foundation Trust | ||
| A Translational Study of Single Agent Olaparib in the Treatment of Advanced Oesophagogastric Cancer | NCT03829345 | Oesophageal Can... Gastro-Oesophag... Gastric Cancer | Olaparib | 18 Years - | Royal Marsden NHS Foundation Trust | |
| EndoVE endosCopic Treatment for Oesophageal and Gastric canceR | NCT04649372 | Oesophageal Can... Oesophageal Dis... Gastric Cancer | EndoVE | 18 Years - | Mirai Medical | |
| HMBD-001 in Advanced HER3 Positive Solid Tumours | NCT05057013 | Bladder Cancer Triple Negative... Castration-resi... Cervical Cancer RAS Wild Type C... Endometrial Can... Gastric Cancer Hepatocellular ... Melanoma Non-small Cell ... Oesophageal Can... Ovarian Cancer Pancreatic Canc... Squamous Cell C... | HMBD-001 | 16 Years - | Cancer Research UK | |
| Quality of Life of Patients Over 75 Yars Undergoing Palliative Chemotherapy | NCT04517448 | Colorectal Canc... Pancreatic Canc... Biliary Cancer Hepatic Cancer Oesophageal Can... Gastric Cancer | 75 Years - | Centre Hospitalier de la côte Basque | ||
| Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors | NCT06302660 | Oesophageal Can... Quality of Life Bacterial Overg... | Breath test Saliva sample Blood sample Urine sample Stool sample Health-related ... | 18 Years - 90 Years | Imperial College London | |
| The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis Esophagectomy | NCT01361750 | Oesophageal Can... | gastric tube | 30 Years - 75 Years | Peking University | |
| Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and Rectum | NCT02526134 | Oesophageal Can... Rectal Cancer | radio opaque ma... | 18 Years - | Institut Paoli-Calmettes | |
| Predictive Value of Pet Scan With Fdg Performed During Irradiation in Patients Treated for Oesaphagus Carcinoma | NCT00934505 | Oesophageal Can... | 18 Years - | Centre Henri Becquerel | ||
| Gastrointestinal Functional Outcome Ivor Lewis | NCT03658837 | Oesophageal Can... | Ivor Lewis Oeso... | 18 Years - | University Hospitals, Leicester | |
| Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients | NCT06414122 | Oesophageal Can... Gastric Cancer Duodenal Cancer Colorectal Canc... | mid-frequency w... conventional ex... nutritional the... | 18 Years - | University of Cologne | |
| Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer | NCT00911092 | Esophageal Canc... | Blood sampling Radiation Chemotherapy (F... | 18 Years - | Centre Oscar Lambret | |
| Prehabilitation Via a Mobile Application in Oesophago-gastric Cancer | NCT06046846 | Oesophageal Can... Gastric Cancer Prehabilitation mHealth Applica... | Asensei app | 18 Years - | Queen Margaret University | |
| A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors | NCT05784597 | Breast Cancer Colorectal Canc... Oesophageal Can... Pancreas Adenoc... | [68Ga]Ga-OncoFA... | 18 Years - 75 Years | Philogen S.p.A. | |
| Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | NCT00359645 | Pharynx Cancer Larynx Cancer Oral Cavity Can... Oesophageal Can... | Screening by he... | 40 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| NY-ESO-1 T Cells in OG Cancer | NCT01795976 | Oesophageal Can... | NY-ESO-1 T cell... cyclophosphamid... Fludarabine Interleukin 2 | 18 Years - | The Christie NHS Foundation Trust | |
| Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis | NCT04508140 | Colorectal Canc... Gastric Cancer Oesophageal Can... | Hepatic Biopsy BO-112 with Pem... | 18 Years - | Highlight Therapeutics | |
| Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel | NCT04237090 | Breast Cancer Lung Cancer Ovarian Cancer Oesophageal Can... Head Cancer Nec... Cervical Cancer Endometrial Can... | Diphenhydramine Cetirizine Lactose pill Sodium chloride... | 18 Years - | Ciusss de L'Est de l'Île de Montréal | |
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY | NCT04481256 | Carcinoma, Squa... Oesophageal Can... | External beam r... Bintrafusp alfa Paclitaxel Carboplatin | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis | NCT05395910 | Peritoneal Carc... | Paclitaxel | 21 Years - 99 Years | National University Hospital, Singapore | |
| Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) | NCT04232735 | Oesophageal Can... Gastric Cancer | Tool and traini... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Upper GI Serial Tumour Biopsies | NCT05233007 | Oesophageal Can... Gastric Cancer | Minor endoscopi... | 18 Years - 100 Years | The Christie NHS Foundation Trust | |
| A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer | NCT05165264 | Gastric Cancer | 18 Years - | Bristol-Myers Squibb | ||
| Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients | NCT06414122 | Oesophageal Can... Gastric Cancer Duodenal Cancer Colorectal Canc... | mid-frequency w... conventional ex... nutritional the... | 18 Years - | University of Cologne | |
| Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab | NCT03653052 | Oesophageal Can... | Durvalumab | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) | NCT04484636 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | FoundationOne®C... | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis | NCT04508140 | Colorectal Canc... Gastric Cancer Oesophageal Can... | Hepatic Biopsy BO-112 with Pem... | 18 Years - | Highlight Therapeutics | |
| A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study | NCT06290505 | Oesophageal Can... | Durvalumab | 18 Years - | Australasian Gastro-Intestinal Trials Group | |
| Implementation and Quality Assurance of DPYD-genotyping in Patients Treated With Fluoropyrimidines. | NCT05266300 | Adverse Drug Ev... Colon Cancer Breast Cancer Pancreas Cancer Rectal Cancer Gastric Cancer Oesophageal Can... Bile Duct Cance... | DPYD genotype | 18 Years - | University of Southern Denmark | |
| Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer | NCT00911092 | Esophageal Canc... | Blood sampling Radiation Chemotherapy (F... | 18 Years - | Centre Oscar Lambret | |
| Nutrition in Gastrointestinal Tumors | NCT04476082 | Pancreatic Canc... Oesophageal Can... Colon Cancer Liver Cancer Rectal Cancer Bile Duct Cance... GIST, Malignant Neuroendocrine ... Small Intestine... Gastric Cancer | No intervention... | 18 Years - | University Medicine Greifswald | |
| PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer | NCT04564482 | Rectal Cancer S... Oesophageal Can... | CRT SCPRT CROSS Protocol PD-L1 PET | 18 Years - 100 Years | Medical University of Vienna | |
| Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) | NCT02465736 | Esophageal Squa... Esophageal Canc... Oesophageal Can... | Docetaxel Cisplatin Radiation Surgery Vinorelbine Cisplatin | 18 Years - 70 Years | Sun Yat-sen University | |
| ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study | NCT01915693 | Oesophageal Can... | Radiotherapy | 16 Years - | Velindre NHS Trust | |
| Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients | NCT06414122 | Oesophageal Can... Gastric Cancer Duodenal Cancer Colorectal Canc... | mid-frequency w... conventional ex... nutritional the... | 18 Years - | University of Cologne | |
| Swedish Oesophago-Gastric Study | NCT05540119 | Oesophageal Can... Gastric Cancer Surgical Treatm... Aetiology Prognostic Fact... Survival Prediction Treatment | Surgery | - | Karolinska Institutet | |
| Cardiopulmonary Toxicity of Thoracic Radiotherapy | NCT03978377 | Oesophageal Can... Non Small Cell ... | 18 Years - | University Medical Center Groningen | ||
| Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation | NCT02741856 | Oesophageal Can... | Carboplatin Paclitaxel Cisplatin Capecitabine Radiotherapy | 17 Years - | Velindre NHS Trust | |
| Augmentation of Volatile Biomarkers of Oesophageal and Gastric Adenocarcinoma From the Tumour Lipidome | NCT05600608 | Breath Test Oesophageal Can... Gastric Cancer Augmentation Diagnoses Disea... | Oral Stimulant ... | 19 Years - 90 Years | Imperial College London | |
| ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) Cancer | NCT04603339 | Oesophageal Can... Gastric Cancer | Multidisciplina... | 18 Years - 100 Years | University of Dublin, Trinity College | |
| M6620 Plus Standard Treatment in Oesophageal and Other Cancer | NCT03641547 | Oesophageal Ade... Squamous Cell C... Solid Tumor | M6620 Cisplatin Capecitabine Radiotherapy | 16 Years - | University of Oxford | |
| Assessing the Accuracy of Seismofit® as an Estimate of VO2 Peak in Patients With Hepato-pancreato-biliary, Colorectal, and Gastro-oesophageal Cancer | NCT05831488 | Hepato-Biliary ... Pancreatic Canc... Colorectal Canc... Gastric Cancer Oesophageal Can... | Non-Interventio... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Physical Activity Intervention Trial to Mitigate Muscle Loss and Increase Muscle Strength | NCT02774551 | Oesophageal Can... | Physical activi... | 18 Years - | Karolinska Institutet | |
| The Effects of Gastric Tube on the Quality of Life and Nutritional Status After Ivor-Lewis Esophagectomy | NCT01361750 | Oesophageal Can... | gastric tube | 30 Years - 75 Years | Peking University | |
| The Association Between Preoperative CPEX and Postoperative Morbidity Following Oesophagectomy | NCT03216694 | Oesophageal Can... | Cardiopulmonary... | - | University of East Anglia | |
| A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study | NCT06290505 | Oesophageal Can... | Durvalumab | 18 Years - | Australasian Gastro-Intestinal Trials Group | |
| PRIORITY-CONNECT 2 Pilot Trial | NCT06212700 | Liver Cancer Pancreas Cancer Oesophageal Can... Gastric Cancer Colorectal Canc... | Preoperative Ex... Postoperative E... Preoperative Nu... Postoperative N... Preoperative Ps... Postoperative P... Preoperative Nu... Postoperative N... Preoperative Pe... Postoperative P... Usual Care | 18 Years - | Surgical Outcomes Research Centre (SOuRCe) | |
| Evidence Based Information Provision to Improve Decision Making After Oesophagogastric Cancer Diagnosis (SOURCE) | NCT04232735 | Oesophageal Can... Gastric Cancer | Tool and traini... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric Cancer | NCT03399071 | Gastric Adenoca... Oesophageal Ade... | FLOT-A | 18 Years - | Royal Marsden NHS Foundation Trust | |
| ReStOre@Home: Feasibility Study of a 12-week Multidisciplinary Telehealth Rehabilitation Programme for Survivors of Upper Gastrointestinal (UGI) Cancer | NCT04603339 | Oesophageal Can... Gastric Cancer | Multidisciplina... | 18 Years - 100 Years | University of Dublin, Trinity College | |
| A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors | NCT05143970 | Metastatic Canc... Metastatic Brea... Metastatic Panc... Metastatic Gast... Metastatic Lung... Metastatic Ovar... Oesophageal Can... Endometrial Can... Advanced Solid ... | IPH5301 ALONE O... | 18 Years - | Institut Paoli-Calmettes | |
| A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer | NCT05165264 | Gastric Cancer | 18 Years - | Bristol-Myers Squibb | ||
| Study of Docetaxel or Vinorelbine Plus Cisplatin in Neoadjuvant Chemoradiotherapy for Esophageal Cancer (NEOCRTEC308) | NCT02465736 | Esophageal Squa... Esophageal Canc... Oesophageal Can... | Docetaxel Cisplatin Radiation Surgery Vinorelbine Cisplatin | 18 Years - 70 Years | Sun Yat-sen University | |
| Non-invasive Testing for Early oEesophageal Cancer and Dysplasia | NCT04001478 | Oesophageal Can... Barrett Esophag... Barretts Esopha... | Breath test | 18 Years - 90 Years | Imperial College London | |
| Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | NCT02735239 | Esophageal Canc... | Durvalumab Tremelimumab Oxaliplatin Capecitabine Radiotherapy Paclitaxel Carboplatin 5-fluorouracil ... Leucovorin Docetaxel | 18 Years - | Ludwig Institute for Cancer Research | |
| Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours | NCT01795768 | Gastric Cancer Oesophageal Can... Breast Cancer Squamous Cell C... | AZD 4547 | 25 Years - | Royal Marsden NHS Foundation Trust | |
| A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer | NCT03416244 | Esophageal Canc... Oesophageal Can... Oesophageal Can... Esophageal Canc... Esophageal Canc... Oesophageal Can... GastroEsophagea... Gastrooesophage... | Nivolumab Ipilimumab | 65 Years - | AIO-Studien-gGmbH | |
| A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer | NCT01843829 | Oesophageal Can... | Oxaliplatin Capecitabine Carboplatin Paclitaxel Radiotherapy Surgery | 18 Years - | Velindre NHS Trust | |
| A Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell Cancer | NCT03416244 | Esophageal Canc... Oesophageal Can... Oesophageal Can... Esophageal Canc... Esophageal Canc... Oesophageal Can... GastroEsophagea... Gastrooesophage... | Nivolumab Ipilimumab | 65 Years - | AIO-Studien-gGmbH | |
| The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study | NCT05804331 | Cancer of Stoma... Oesophageal Can... Gastric Cancer Gastric Adenoca... GI Cancer GIST Neuroendocrine ... Gastric Neoplas... Esophageal Neop... | 18 Years - | Western Sydney Local Health District | ||
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Quality of Life After Oesophageal or Gastric Cancer Surgery | NCT01657175 | Quality of Life Oesophageal Can... Gastric Cancer | Supportive care | 18 Years - | Region Skane |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
